Skip to main content

Autonomix Medical, Inc.

For the period ended Mar 31, 2025. Filed May 29, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed May 29, 2025

AMIX$1.70+11.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

PART I
Item 1.Business4
Item 1A.Risk Factors20
Item 1B.Unresolved Staff Comments37
Item 1C.Cybersecurity37
Item 2.Properties38
Item 3.Legal Proceedings38
Item 4.Mine Safety Disclosures38
PART II
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities39
Item 6.Reserved39
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations39
Item 7A.Quantitative and Qualitative Disclosure About Market Risk46
Item 8.Financial Statements and Supplementary Data46
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosures64
Item 9A.Controls and Procedures64
Item 9B.Other Information65
Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections65
PART III66
Item 10.Directors, Executive Officers and Corporate Governance66
Item 11.Executive Compensation66
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters66
Item 13.Certain Relationships and Related Transactions and Director Independence66
Item 14.Principal Accounting Fees and Services66
PART IV67
Item 15.Exhibits, Financial Statement Schedules67

References in this Annual Report on Form 10-K to“we,"“us,"”its,"“our”* or the*“Company”* are to Autonomix Medical, Inc. (“Autonomix”), as appropriate to the context.*

Cautionary Statement About Forward-Looking Statements

This Annual Report on Form 10-K (including the section regarding Management’s Discussion and Analysis of Financial Condition and Results of Operations, the Annual Report) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “should,” “would,” “could,” "will", “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” "seek," "contemplate," "project," “potential," “continue," or "ongoing" and the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. In particular, you should consider the numerous risks and uncertainties described under “Risk Factors” and in other filings made by us from time to time with the SEC.

While we believe we have identified material risks, these risks and uncertainties are not exhaustive. Other sections of this Annual Report on Form 10-K may describe additional factors that could adversely impact our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this Annual Report on Form 10-K to conform our prior statements to actual results or revised expectations, and we do not intend to do so.

Forward-looking statements include, but are not limited to, statements about:

•our ability to continue as a going concern in the near term is dependent upon us successfully raising additional equity or debt financing to fund our operations;
•the success of our future clinical trials;
•we currently have no source of product sales revenue;
•competition from existing products or new products that may emerge;
•if we fail to comply with U.S. and foreign regulatory requirements, regulatory authorities could limit or withdraw any marketing or commercialization approvals we may receive and subject us to other penalties that could materially harm our business;
•we may be unable to obtain U.S. or foreign regulatory approval and, as a result, unable to commercialize our product candidates;
•the implementation of our business model and strategic plans for our business, technologies and product candidates;
•potential product liability claims;
•our dependency on third-party supply and manufacturing partners to supply the materials and components for, and manufacture, our research and development, preclinical and clinical trial devices;
•our ability to establish or maintain collaborations, licensing or other arrangements and retain commercial rights for our product candidates subject to collaborations;
•our ability and third parties’ abilities to protect intellectual property rights and our ability to operate our business without infringing the intellectual property rights of others;
•our ability to adequately support future growth;
•our estimates of our expenses, ongoing losses, future revenue and capital requirements;
•our ability to attract and retain key management personnel and technical personnel to manage our business effectively;
•risks associated with our identification of material weaknesses in our control over financial reporting;
•our use of net proceeds received by us from any subsequent private placement or public financing;
•natural disasters affecting us, our primary manufacturer or our suppliers;
•our ability to establish relationships with health care professionals and organizations;
•general economic uncertainty that adversely affects spending on medical procedures;
•volatility in the market price of our stock; and
•potential dilution to current stockholders from the issuance of equity awards.

We caution you not to place undue reliance on the forward-looking statements, which speak only as of the date of this Annual Report on Form 10-K in the case of forward-looking statements contained in this Annual Report on Form 10-K.

You should not rely upon forward-looking statements as predictions of future events. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Therefore, you should not rely on any of the forward-looking statements. In addition, with respect to all of our forward-looking statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.